294 related articles for article (PubMed ID: 31752884)
21. Outcome of radical local treatment of non-small cell lung cancer patients with synchronous oligometastases.
Kwint M; Walraven I; Burgers S; Hartemink K; Klomp H; Knegjens J; Verheij M; Belderbos J
Lung Cancer; 2017 Oct; 112():134-139. PubMed ID: 29191586
[TBL] [Abstract][Full Text] [Related]
22. Gender Differences in Long-Term Survival after Surgery for Non-Small Cell Lung Cancer.
Yoshida Y; Murayama T; Sato Y; Suzuki Y; Saito H; Nomura Y
Thorac Cardiovasc Surg; 2016 Sep; 64(6):507-14. PubMed ID: 26366891
[TBL] [Abstract][Full Text] [Related]
23. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.
Dillman RO; Herndon J; Seagren SL; Eaton WL; Green MR
J Natl Cancer Inst; 1996 Sep; 88(17):1210-5. PubMed ID: 8780630
[TBL] [Abstract][Full Text] [Related]
24. Effect of PET/CT standardized uptake values on complete response to treatment before definitive chemoradiotherapy in stage III non-small cell lung cancer.
Ercelep O; Alan O; Sahin D; Telli TA; Salva H; Tuylu TB; Babacan NA; Kaya S; Dane F; Ones T; Alkis H; Adli M; Yumuk F
Clin Transl Oncol; 2019 Apr; 21(4):499-504. PubMed ID: 30229391
[TBL] [Abstract][Full Text] [Related]
25. Three-Dimensional Radiation Therapy to the Primary Tumor With Concurrent Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer: Results of a Multicenter Phase 2 Study From PPRA-RTOG, China.
Su S; Li T; Lu B; Wang X; Li J; Chen M; Lu Y; Bai Y; Hu Y; Ouyang W; Ma Z; Li Q; Li H; Wang Y
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):769-77. PubMed ID: 26530745
[TBL] [Abstract][Full Text] [Related]
26. The prognostic impact of tumor volume on stage I non-small cell lung cancer.
Su XD; Xie HJ; Liu QW; Mo YX; Long H; Rong TH
Lung Cancer; 2017 Feb; 104():91-97. PubMed ID: 28213008
[TBL] [Abstract][Full Text] [Related]
27. Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450).
De Ruysscher D; Wanders R; Hendriks LE; van Baardwijk A; Reymen B; Houben R; Bootsma G; Pitz C; van Eijsden L; Dingemans AC
J Thorac Oncol; 2018 Dec; 13(12):1958-1961. PubMed ID: 30253974
[TBL] [Abstract][Full Text] [Related]
28. Feasibility and efficacy of salvage lung resection after definitive chemoradiation therapy for Stage III non-small-cell lung cancer.
Shimada Y; Suzuki K; Okada M; Nakayama H; Ito H; Mitsudomi T; Saji H; Takamochi K; Kudo Y; Hattori A; Mimae T; Aokage K; Nishii T; Tsuboi M; Ikeda N
Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):895-901. PubMed ID: 27543652
[TBL] [Abstract][Full Text] [Related]
29. Prospective Study of Serial Imaging Comparing Fluorodeoxyglucose Positron Emission Tomography (PET) and Fluorothymidine PET During Radical Chemoradiation for Non-Small Cell Lung Cancer: Reduction of Detectable Proliferation Associated With Worse Survival.
Everitt S; Ball D; Hicks RJ; Callahan J; Plumridge N; Trinh J; Herschtal A; Kron T; Mac Manus M
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):947-955. PubMed ID: 29063854
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of total lesion glycolysis and metabolic active tumor volume in non-small cell lung cancer.
Vanhove K; Mesotten L; Heylen M; Derwael R; Louis E; Adriaensens P; Thomeer M; Boellaard R
Cancer Treat Res Commun; 2018; 15():7-12. PubMed ID: 30207286
[TBL] [Abstract][Full Text] [Related]
31. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
Sher DJ; Koshy M; Liptay MJ; Fidler MJ
Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
[TBL] [Abstract][Full Text] [Related]
32. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
Tokito T; Azuma K; Kawahara A; Ishii H; Yamada K; Matsuo N; Kinoshita T; Mizukami N; Ono H; Kage M; Hoshino T
Eur J Cancer; 2016 Mar; 55():7-14. PubMed ID: 26771872
[TBL] [Abstract][Full Text] [Related]
33. Five-year lung cancer survival: which advanced stage nonsmall cell lung cancer patients attain long-term survival?
Wang T; Nelson RA; Bogardus A; Grannis FW
Cancer; 2010 Mar; 116(6):1518-25. PubMed ID: 20108308
[TBL] [Abstract][Full Text] [Related]
34. Increasing Rates of No Treatment in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Propensity-Matched Analysis.
David EA; Daly ME; Li CS; Chiu CL; Cooke DT; Brown LM; Melnikow J; Kelly K; Canter RJ
J Thorac Oncol; 2017 Mar; 12(3):437-445. PubMed ID: 28109804
[TBL] [Abstract][Full Text] [Related]
35. Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer.
Parikh RB; Cronin AM; Kozono DE; Oxnard GR; Mak RH; Jackman DM; Lo PC; Baldini EH; Johnson BE; Chen AB
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):880-7. PubMed ID: 24867533
[TBL] [Abstract][Full Text] [Related]
36. Treating locally advanced disease: an analysis of very large, hilar lymph node positive non-small cell lung cancer using the National Cancer Data Base.
Moreno AC; Morgensztern D; Boffa DJ; Decker RH; Yu JB; Detterbeck FC; Wang Z; Rose MG; Kim AW
Ann Thorac Surg; 2014 Apr; 97(4):1149-55. PubMed ID: 24582051
[TBL] [Abstract][Full Text] [Related]
37. 18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer.
Eschmann SM; Friedel G; Paulsen F; Reimold M; Hehr T; Budach W; Langen HJ; Bares R
Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):463-71. PubMed ID: 17103167
[TBL] [Abstract][Full Text] [Related]
38. The survival outcomes and prognosis of stage IV non-small-cell lung cancer treated with thoracic three-dimensional radiotherapy combined with chemotherapy.
Su S; Hu Y; Ouyang W; Ma Z; Lu B; Li Q; Li H; Wang Z; Wang Y
Radiat Oncol; 2014 Dec; 9():290. PubMed ID: 25518882
[TBL] [Abstract][Full Text] [Related]
39. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
Li J; Dai CH; Yu LC; Chen P; Li XQ; Shi SB; Wu JR
Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic analysis of advanced non small cell lung cancer treated by sequential chemo-radiation therapy combined with traditional Chinese medicine: a report of 54 cases].
Han MQ; Su JM; Huang HY; Long WH; Qin LP; Qin P; Liu W; Sheng ZY
Zhong Xi Yi Jie He Xue Bao; 2003 Sep; 1(3):195-8. PubMed ID: 15339560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
